Jakub Mateusz Kryczka

9PUBLICATIONS
21CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersOrthopticsMedical mycologyChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 20, 2026
Bis-(di-4-phenyl-benzylaminethiocarbonyl)disulfide sensitizes ABCC2/ALDH3A1 overexpressing NSCLC cells to cisplatin.

|Aug 20, 2025
A preliminary bioinformatic screen to identify SRI SMC2 PSIP1 TLE4 and MSX1 as potential diagnostic and prognostic markers of osteoarthritis.

Jolanta Kryczka, Ewa Brzeziańska-Lasota, Michał Pikuła

|Feb 26, 2025
The Expression Level of SOX Family Transcription Factors' mRNA as a Diagnostic Marker for Osteoarthritis.

Kamila Baran, Ewa Brzeziańska-Lasota, Jakub Kryczka

|Nov 27, 2024
Radial Data Visualization-Based Step-by-Step Eliminative Algorithm to Predict Colorectal Cancer Patients' Response to FOLFOX Therapy.

Jakub Kryczka, Rafał Adam Bachorz, Jolanta Kryczka

|Dec 09, 2023
Characteristics of ABCC4 and ABCG2 High Expression Subpopulations in CRC-A New Opportunity to Predict Therapy Response.

Jakub Kryczka, Joanna Boncela

|Oct 28, 2023
Evening Primrose Extract Modulates TYMS Expression via SP1 Transcription Factor in Malignant Pleural Mesothelioma.

Małgorzata Chmielewska-Kassassir, Katarzyna Sobierajska, Wojciech M Ciszewski

Pageof 2

Frequent Collaborators

7 joint publications

Joanna Boncela

6 joint publications

Ewa Brzeziańska-Lasota

5 joint publications

Jolanta Kryczka

3 joint publications

Beata Kolesińska